Cresco to enter FL medical marijuana market via $120M VidaCann purchase

Don’t miss the opportunity to attend MJBizCon 2023 with tickets starting at $99 for a limited time! Dare to join us? Buy your ticket today.

Cresco Labs, a Chicago-based vertically integrated cannabis company, agreed to acquire Florida medical marijuana provider VidaCann in a $120 million cash and stock deal.

The deal gives Cresco a presence in Florida for the first time, expanding its operations into eight states and giving the company a toehold in a major MMJ market.

VidaCann plans to have 20 operating dispensaries by the end of 2019 and has a license for up to 30 in the Sunshine State.

The company currently has seven dispensaries and a 70,000-square-foot cultivation facility that’s expected to double in size by the end of the year.

More details on the deal can be found here.

Cresco, which trades on the Canadian Securities Exchange under the ticker symbol CL, has made no secret of its intention to expand into Florida.

CEO Charlie Bachtell told MJBizDaily Investor Intelligence last week that the state was one of it targets, along with Connecticut, New Jersey and Virginia.